Rob Ter Heine

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 42

Top Topics

Liquid Chromatography

Clinical Practice

Methicillin Resistant Staphylococcus Aureus

Tandem Mass Spectrometry

Top Venues

British journal of clinical pharmacology

Targeted oncology

Clinical pharmacokinetics

Journal of psychopharmacology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Marise R Heerma van Voss, Jessica C L Notohardjo, Joyce M van Dodewaard-de Jong, Haiko J Bloemendal, Rob Ter Heine
A sub-pharmacological test dose does not predict individual docetaxel exposure in prostate cancer patients. Cancer chemotherapy and pharmacology (2024)
Marise R Heerma van Voss, Jessica C L Notohardjo, Joyce M van Dodewaard-de Jong, Haiko J Bloemendal, Rob Ter Heine
A sub-pharmacological test dose does not predict individual docetaxel exposure in prostate cancer patients. Cancer chemotherapy and pharmacology (2024)
Astrid Heida, Nynke G L Jager, Rob E Aarnoutse, Brenda C M de Winter, Huib de Jong, Ron J Keizer, Elisabeth A M Cornelissen, Rob Ter Heine
Model-informed dose optimization of mycophenolic acid in pediatric kidney transplant patients. European journal of clinical pharmacology (2024)
Thomas Knuijver, Rob Ter Heine, Arnt F A Schellekens, Paniz Heydari, Luc Lucas, Sjoerd Westra, Maarten Belgers, Toon van Oosteren, Robbert Jan Verkes, Cornelis Kramers
The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients. Journal of psychopharmacology (Oxford, England) 38 (5) (2024)
Dirk Jan A R Moes, Jeroen J M A Hendrikx, Henk-Jan Guchelaar, Ron H J Mathijssen, J L Bakker, Vincent O Dezentjé, Nikki de Rouw, Nielka P van Erp, Egbert F Smit, Michel van den Heuvel, Thijs H Oude Munnink, Maartje van Kats, Sander Croes, Judith R Kroep, Juliette Zwaveling, Rob Ter Heine
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan. Targeted oncology (2024)
Thomas Knuijver, Rob Ter Heine, Arnt F A Schellekens, Paniz Heydari, Luc Lucas, Sjoerd Westra, Maarten Belgers, Toon van Oosteren, Robbert Jan Verkes, Cornelis Kramers
The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients. Journal of psychopharmacology (Oxford, England) (2024)
Thomas Knuijver, Rob Ter Heine, Arnt F A Schellekens, Paniz Heydari, Luc Lucas, Sjoerd Westra, Maarten Belgers, Toon van Oosteren, Robbert Jan Verkes, Cornelis Kramers
The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients. Journal of psychopharmacology (Oxford, England) 38 (5) (2024)
Marise R Heerma van Voss, Jessica C L Notohardjo, Joyce M van Dodewaard-de Jong, Haiko J Bloemendal, Rob Ter Heine
A sub-pharmacological test dose does not predict individual docetaxel exposure in prostate cancer patients. Cancer chemotherapy and pharmacology (2024)
Esther M Hollander, Nachel M C Zimmerman, Berber Piet, Michel M van den Heuvel, David M Burger, Lindsey H M Te Brake, Rob Ter Heine
Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method to quantify the small molecule inhibitors adagrasib, alectinib, brigatinib, capmatinib, crizotinib, lorlatinib, selpercatinib, and sotorasib in human plasma. Biomedical chromatography : BMC (2024)
Thomas Knuijver, Rob Ter Heine, Arnt F A Schellekens, Paniz Heydari, Luc Lucas, Sjoerd Westra, Maarten Belgers, Toon van Oosteren, Robbert Jan Verkes, Cornelis Kramers
The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients. Journal of psychopharmacology (Oxford, England) 38 (5) (2024)
Rob Ter Heine, Michel M van den Heuvel, Berber Piet, Maarten J Deenen, Anthonie J van der Wekken, Lizza E L Hendriks, Sander Croes, Robin M J M van Geel, Frank G A Jansman, Rogier C Boshuizen, Eric J F Franssen, Arthur A J Smit, Daphne W Dumoulin, Thijs H Oude Munnink, Egbert F Smit, Hieronymus J Derijks, Cor H van der Leest, Jeroen J M A Hendrikx, Dirk J A R Moes, Nikki de Rouw
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer. Targeted oncology (2023)
Rob Ter Heine, Michel M van den Heuvel, Berber Piet, Maarten J Deenen, Anthonie J van der Wekken, Lizza E L Hendriks, Sander Croes, Robin M J M van Geel, Frank G A Jansman, Rogier C Boshuizen, Eric J F Franssen, Arthur A J Smit, Daphne W Dumoulin, Thijs H Oude Munnink, Egbert F Smit, Hieronymus J Derijks, Cor H van der Leest, Jeroen J M A Hendrikx, Dirk J A R Moes, Nikki de Rouw
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer. Targeted oncology (2023)
Anouk M E Jansen, Beatrijs Mertens, Isabel Spriet, Paul E Verweij, Jeroen A Schouten, Joost Wauters, Yves Debaveye, Rob Ter Heine, Roger J M Brüggemann
Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies. Clinical pharmacokinetics (2023)
Rob Ter Heine, Michel M van den Heuvel, Berber Piet, Maarten J Deenen, Anthonie J van der Wekken, Lizza E L Hendriks, Sander Croes, Robin M J M van Geel, Frank G A Jansman, Rogier C Boshuizen, Eric J F Franssen, Arthur A J Smit, Daphne W Dumoulin, Thijs H Oude Munnink, Egbert F Smit, Hieronymus J Derijks, Cor H van der Leest, Jeroen J M A Hendrikx, Dirk J A R Moes, Nikki de Rouw
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer. Targeted oncology (2023)
Rob Ter Heine, Michel M van den Heuvel, Berber Piet, Maarten J Deenen, Anthonie J van der Wekken, Lizza E L Hendriks, Sander Croes, Robin M J M van Geel, Frank G A Jansman, Rogier C Boshuizen, Eric J F Franssen, Arthur A J Smit, Daphne W Dumoulin, Thijs H Oude Munnink, Egbert F Smit, Hieronymus J Derijks, Cor H van der Leest, Jeroen J M A Hendrikx, Dirk J A R Moes, Nikki de Rouw
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer. Targeted oncology 18 (3) (2023)
Didi Bury, Tom F W Wolfs, Rob Ter Heine, Eline W Muilwijk, Kim C M van der Elst, Wim J E Tissing, Roger J M Brüggemann
Pharmacokinetic investigations of isavuconazole in paediatric cancer patients show reduced exposure of isavuconazole after opening capsules for administration via a nasogastric tube. The Journal of antimicrobial chemotherapy (2023)
Rob Ter Heine, Michel M van den Heuvel, Berber Piet, Maarten J Deenen, Anthonie J van der Wekken, Lizza E L Hendriks, Sander Croes, Robin M J M van Geel, Frank G A Jansman, Rogier C Boshuizen, Eric J F Franssen, Arthur A J Smit, Daphne W Dumoulin, Thijs H Oude Munnink, Egbert F Smit, Hieronymus J Derijks, Cor H van der Leest, Jeroen J M A Hendrikx, Dirk J A R Moes, Nikki de Rouw
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer. Targeted oncology 18 (3) (2023)
Rob Ter Heine, Michel M van den Heuvel, Berber Piet, Maarten J Deenen, Anthonie J van der Wekken, Lizza E L Hendriks, Sander Croes, Robin M J M van Geel, Frank G A Jansman, Rogier C Boshuizen, Eric J F Franssen, Arthur A J Smit, Daphne W Dumoulin, Thijs H Oude Munnink, Egbert F Smit, Hieronymus J Derijks, Cor H van der Leest, Jeroen J M A Hendrikx, Dirk J A R Moes, Nikki de Rouw
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer. Targeted oncology (2023)
Rob Ter Heine, Michel M van den Heuvel, Berber Piet, Maarten J Deenen, Anthonie J van der Wekken, Lizza E L Hendriks, Sander Croes, Robin M J M van Geel, Frank G A Jansman, Rogier C Boshuizen, Eric J F Franssen, Arthur A J Smit, Daphne W Dumoulin, Thijs H Oude Munnink, Egbert F Smit, Hieronymus J Derijks, Cor H van der Leest, Jeroen J M A Hendrikx, Dirk J A R Moes, Nikki de Rouw
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer. Targeted oncology 18 (3) (2023)
Demy A C van den Haak, Leila-Sophie Otten, Hans J P M Koenen, Ruben L Smeets, Berber Piet, Peter Pickkers, Matthijs Kox, Rob Ter Heine
Evidence-based rationale for low dose nivolumab in critically ill patients with sepsis-induced immunosuppression. Clinical and translational science (2023)
Rob Ter Heine, Michel M van den Heuvel, Berber Piet, Maarten J Deenen, Anthonie J van der Wekken, Lizza E L Hendriks, Sander Croes, Robin M J M van Geel, Frank G A Jansman, Rogier C Boshuizen, Eric J F Franssen, Arthur A J Smit, Daphne W Dumoulin, Thijs H Oude Munnink, Egbert F Smit, Hieronymus J Derijks, Cor H van der Leest, Jeroen J M A Hendrikx, Dirk J A R Moes, Nikki de Rouw
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer. Targeted oncology 18 (3) (2023)
Jeroen Diepstraten, Anne van Rongen, Marianne P Zijlstra, Marieke J H A Kruip, Pim L J van der Heiden, Rob Ter Heine
Low and Highly Variable Exposure to Prophylactic LMWH Nadroparin in Critically Ill Patients: Back to the Drawing Board for Prophylactic Dosing? Clinical pharmacokinetics 62 (2) (2022)
Jeroen Diepstraten, Anne van Rongen, Marianne P Zijlstra, Marieke J H A Kruip, Pim L J van der Heiden, Rob Ter Heine
Low and Highly Variable Exposure to Prophylactic LMWH Nadroparin in Critically Ill Patients: Back to the Drawing Board for Prophylactic Dosing? Clinical pharmacokinetics (2022)
Jeroen Diepstraten, Anne van Rongen, Marianne P Zijlstra, Marieke J H A Kruip, Pim L J van der Heiden, Rob Ter Heine
Low and Highly Variable Exposure to Prophylactic LMWH Nadroparin in Critically Ill Patients: Back to the Drawing Board for Prophylactic Dosing? Clinical pharmacokinetics (2022)
Mendy Ter Avest, Saskia M C Langemeijer, Nicole M A Blijlevens, Nicole C A J van de Kar, Rob Ter Heine
Dose optimalization of subcutaneous ravulizumab is predicted to yield significant savings and to improve patient friendliness. British journal of clinical pharmacology (2022)
Jeroen Diepstraten, Anne van Rongen, Marianne P Zijlstra, Marieke J H A Kruip, Pim L J van der Heiden, Rob Ter Heine
Low and Highly Variable Exposure to Prophylactic LMWH Nadroparin in Critically Ill Patients: Back to the Drawing Board for Prophylactic Dosing? Clinical pharmacokinetics 62 (2) (2022)
Jeroen Diepstraten, Anne van Rongen, Marianne P Zijlstra, Marieke J H A Kruip, Pim L J van der Heiden, Rob Ter Heine
Low and Highly Variable Exposure to Prophylactic LMWH Nadroparin in Critically Ill Patients: Back to the Drawing Board for Prophylactic Dosing? Clinical pharmacokinetics (2022)
Simon E Koele, Stijn W van Beek, Anthonie J van der Wekken, Berber Piet, Michel M van den Heuvel, Rob Ter Heine
Pharmacokinetically guided dosing to improve the efficacy of brigatinib in non-small cell lung cancer patients. British journal of clinical pharmacology 88 (8) (2022)
Didi Bury, Tom F W Wolfs, Rob Ter Heine, Eline W Muilwijk, Wim J E Tissing, Roger J M Brüggemann
Pharmacokinetic evaluation of twice-a-week micafungin for prophylaxis of invasive fungal disease in children with acute lymphoblastic leukaemia: a prospective observational cohort study. The Journal of antimicrobial chemotherapy 77 (3) (2022)
René J Boosman, Nikki de Rouw, Alwin D R Huitema, Jacobus A Burgers, Rob Ter Heine
Prediction of the pharmacokinetics of pemetrexed with a low test dose: A proof-of-concept study. British journal of clinical pharmacology (2022)
Anouk van der Veen, Annemie Somers, Sophie Vanhaesebrouck, Rob Ter Heine, Roger J M Brüggemann, Karel Allegaert, Pieter A J G de Cock
Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units. International journal of clinical pharmacy (2021)
Anne M Schijvens, Saskia N de Wildt, Elisabeth A M Cornelissen, Fransje H S van Hesteren, Michiel F Schreuder, Rob Ter Heine
Low Bioavailability of Oral Tacrolimus Suspension in Pediatric Kidney Transplant Patients. Clinical pharmacokinetics 59 (11) (2021)
Nikki de Rouw, Hieronymus J Derijks, Luuk B Hilbrands, René J Boosman, Berber Piet, Stijn L W Koolen, Jacobus A Burgers, Anne-Marie C Dingemans, Michel M van den Heuvel, Lizza E L Hendriks, Joachim G J V Aerts, Sander Croes, Ron H J Mathijssen, Alwin D R Huitema, David Marinus Burger, Bonne Biesma, Rob Ter Heine
Hyperhydration with cisplatin does not influence pemetrexed exposure. British journal of clinical pharmacology (2021)
Simon E Koele, Stijn W van Beek, Anthonie J van der Wekken, Berber Piet, Michel M van den Heuvel, Rob Ter Heine
Pharmacokinetically-guided dosing to improve the efficacy of brigatinib in non-small cell lung cancer patients. British journal of clinical pharmacology (2021)
Mendy Ter Avest, Saskia M C Langemeijer, Saskia E M Schols, David Marinus Burger, Nicole C A J van de Kar, Nicole M A Blijlevens, Wietske Kievit, Rob Ter Heine
The potential of individualized dosing of ravulizumab to improve patient-friendliness of paroxysmal nocturnal haemoglobinuria treatment at reduced costs. British journal of clinical pharmacology 87 (8) (2021)
Eleonora W J van Ewijk-Beneken Kolmer, Marga J A Teulen, Rene J Boosman, Nikki de Rouw, Jacobus A Burgers, Rob Ter Heine
Highly sensitive quantification of pemetrexed in human plasma using UPLC-MS/MS to support microdosing studies. Biomedical chromatography : BMC (2021)
Rob Ter Heine, Ron J Keizer, Krista van Steeg, Elise J Smolders, Matthijs van Luin, Hieronymus J Derijks, Cornelis P C de Jager, Tim Frenzel, Roger J M Brüggemann
Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patients. British journal of clinical pharmacology 86 (12) (2020)
Stijn W van Beek, Rob Ter Heine, Ron J Keizer, Cecile Magis-Escurra, Rob E Aarnoutse, Elin M Svenson
Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin. Clinical pharmacokinetics 58 (6) (2020)
Didi Bury, Rob Ter Heine, Ewoudt M W van de Garde, Marten R Nijziel, Rene J Grouls, Maarten J Deenen
The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults. European journal of clinical pharmacology 75 (7) (2019)
Rob Ter Heine, Sean P Kane, Alwin D R Huitema, Matthew D Krasowski, Erik M van Maarseveen
Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction model. British journal of clinical pharmacology 85 (10) (2019)
Loek A W de Jong, Fortuné M K Elekonawo, Philip R de Reuver, Andre J A Bremers, Johannes H W de Wilt, Frank G A Jansman, Rob Ter Heine, Nielka P van Erp
Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure. British journal of clinical pharmacology 85 (1) (2018)
Guillemette Emma Benoist, Maarten J van der Doelen, Rob Ter Heine, Nielka P van Erp, Niven Mehra
A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration-resistant metastatic prostate cancer. British journal of clinical pharmacology 84 (5) (2018)